Uptrend Call Working As Halozyme Therapeutics Stock Rises 15.8% (HALO)

SmarTrend identified an Uptrend for Halozyme Therapeutics (NASDAQ:HALO) on August 4th, 2016 at $10.38. In approximately 2 months, Halozyme Therapeutics has returned 15.76% as of today's recent price of...